Current surgical treatment of esophagogastric junction adenocarcinoma

World J Gastrointest Oncol. 2019 Aug 15;11(8):567-578. doi: 10.4251/wjgo.v11.i8.567.

Abstract

The incidence of esophagogastric junction (EGJ) adenocarcinoma has shown an upward trend over the past several decades worldwide. In this article, we review previous studies and aimed to provide an update on the factors related to the surgical treatment of EGJ adenocarcinoma. The Siewert classification has implications for lymph node spread and is the most commonly used classification. Different types of EGJ cancer have different incidences of mediastinal and abdominal lymph node metastases, and different surgical approaches have unique advantages and disadvantages. Minimally invasive surgeries have been increasingly applied in clinical practice and show comparable oncologic outcomes. Endoscopic resection may be a good therapy for early EGJ cancer. Additionally, there is still a great need for well-designed, large RCTs to forward our knowledge on the surgical treatment of EGJ cancer.

Keywords: Esophagogastric junction cancer; Lymph nodes; Siewert classification; Surgery.

Publication types

  • Review